CD27 and acute myeloid leukemia: Stem cell markers CD82 [66], CD70/CD27, and Wnt receptor Fzd1 are correlated in their proliferation and chemotherapy resistance for AML cells via activation of the Wnt–β-catenin signaling pathway.